WederAB. Genetics and hypertension. J Clin Hypertens (Greenwich). 2007;9(3):217–223.
2.
LiftonRP. Molecular genetics of human blood pressure variation. Science. 1996;272(5262):676–680.
3.
LiftonRPDluhyRGPowersM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355(6357):262–265.
4.
ShimketsRAWarnockDGBositisCM. Liddle’s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell. 1994;79(3):407–414.
5.
MuneTRogersonFMNikkilaHAgarwalAKWhitePC. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet. 1995;10(4):394–399.
6.
GellerDSFarhiAPinkertonN. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 2000;289(5476):119–123.
7.
JeunemaitreXSoubrierFKotelevtsevYV. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71(1):169–180.
8.
AtlasSA. The renin–angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8 suppl B):9–20.
9.
CaulfieldMLavenderPFarrallM. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330(23):1629–1633.
10.
PereiraTVNunesACRudnickiMYamadaYPereiraACKriegerJE. Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension: a role beyond M235T?Hypertension. 2008;51(3):778–83.
11.
LiHDuZZhangL. The relationship between angiotensinogen gene polymorphisms and essential hypertension in a Northern Han Chinese population[published online on May 28, 2013]. Angiology. 2013. doi: 10.1177/0003319713491309
12.
XiBShenYYanYMiJ. Association of polymorphisms in the AGT gene with essential hypertension in the Chinese population. J Renin Angiotensin Aldosterone Syst. 2012;13(2):282–288.
13.
LiYY. Lack of association of A-6G polymorphism of AGT gene with essential hypertension in the Chinese population. J Cardiovasc Med (Hagerstown). 2012;13(8):505–510.
14.
BakerMRahmanTHallD. The C-532T polymorphism of the angiotensinogen gene is associated with pulse pressure: a possible explanation for heterogeneity in genetic association studies of AGT and hypertension. Int J Epidemiol. 2007;36(6):1356–1362.
15.
GuCCChangYPHuntSC. Haplotype association analysis of AGT variants with hypertension-related traits: the HyperGEN study. Hum Hered. 2005;60(3):164–176.
16.
Balam-OrtizEEsquivel-VillarrealAHuerta-HernandezD. Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension. Hypertension. 2012;59(4):847–853.
17.
SethiAANordestgaardBGTybjaerg-HansenA. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2003;23(7):1269–1275.
18.
WangWYGlennCLZhangWBenjafieldAVNyholtDRMorrisBJ. Exclusion of angiotensinogen gene in molecular basis of human hypertension: sibpair linkage and association analyses in Australian anglo-caucasians. Am J Med Genet. 1999;87(1):53–60.
19.
BoreckiIBProvinceMALudwigEH. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: the NHLBI Family Heart Study. Ann Epidemiol. 1997;7(1):13–21.
20.
HataANamikawaCSasakiM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994;93(3):1285–1287.
21.
MartinezEPurasAEscribanoJ. Threonines at position 174 and 235 of the angiotensinogen polypeptide chain are related to familial history of hypertension in a Spanish-Mediterranean population. Br J Biomed Sci. 2002;59(2):95–100.
22.
InoueINakajimaTWilliamsCS. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99(7):1786–1797.
23.
IshigamiTUmemuraSTamuraK. Essential hypertension and 5 upstream core promoter region of human angiotensinogen gene. Hypertension. 1997;30(6):1325–1330.
24.
LeeJKWuCKTsaiCT. Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: a 12-year follow-up study. Pharmacogenet Genomics. 2013;23(4):181–189.
25.
JohnsonADNewton-ChehCChasmanDI; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium; Global BPgen Consortium; Women's Genome Health Study. Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension. 2011;57(5):903–910.
26.
YuHLinSLiuGZhangYDengCMaW. T1198C polymorphism of the angiotensinogen gene and antihypertensive response to angiotensin-converting enzyme inhibitors. Hypertens Res. 2005;28(12):981–986.
